EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Evaluation of the safety and effectiveness of crural reinforcement with bio-a® or phasix-st® mesh: results from a multicenter study

Alberto Aiolfi, Davide Bona iD, Sara De Bernardi, Francesca Lombardo, Michele Manara, Gianluca Bonitta, Quan Wang, Marta Cavalli, Giampiero Campanelli, Luigi Bonavina

Hernia · 2025

DOI: 10.1007/s10029-025-03516-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Hernia, 2025. Verfasst von Alberto Aiolfi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, Department of Biomedical Science for Health, I.R.C.C.S. Ospedale Galeazzi - Sant'Ambrogio, University of Milan, Via C. B…. Hauptthemen laut MEDLINE: Surgical Mesh, Herniorrhaphy, Hernia, Hiatal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Absorbable synthetic meshes have gained increasing acceptance for crural reinforcement during hiatus hernia (HH) repair because their safety profile and the potential of reducing recurrence rates. Bio-A ® (Gore Medical, Newark, DE, USA) and Phasix-ST ® (C.R. Bard, Inc./Davol, Inc., Warwick, RI, USA) are the most commonly used meshes. While previous single-arm studies have been published, there are no articles reporting the comparison between Phasix-ST ® vs. Bio-A ® .

Aim

Compare safety, efficacy, recurrence rates, and quality of life after laparoscopic HH repair and cruroplasty reinforced with either Bio-A ® or Phasix-ST ® mesh.

Methods

Retrospective multicenter study (September 2011- December 2024). All patients that underwent minimally invasive HH repair with Phasix-ST ® or Bio-A ® reinforced cruroplasty and Toupet fundoplication were included.

Results

Overall, 271 patients were included. Bio-A ® reinforcement was utilized in 46.8% of patients. The median follow-up time was 94 (IQR 21) months for Bio-A ® and 51 (IQR 17) months for Phasix-ST ® mesh. Hernia recurrence was diagnosed in 10.1% of patients with similar rates for Phasix-ST ® vs. Bio-A ® (7.8% vs. 12.6%; p = 0.28). The regression analysis showed that Phasix-ST ® (HR 0.66), ‘keyhole’ configuration (HR 0.81), hernia type III-IV (HR 1.38), and recurrent HH (HR 1.27) were not independent predictor or protective factors for recurrence. The 55-month recurrence free probability for Bio-A ® vs. Phasix-ST ® was comparable (86.2% vs. 91.8%; p = 0.132).

Conclusions

This study shows that Bio-A ® and Phasix-ST ® are equally safe for crural reinforcement during HH repair. Due to the longer absorption rate, Phasix ST ® might presumably confer enhanced hiatal protection early in the course of the follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surgical MeshHerniorrhaphyHernia, HiatalHumansRetrospective StudiesFemaleMaleMiddle AgedRecurrenceLaparoscopyAgedTreatment OutcomeQuality of LifeFundoplication

Stichwörter der Autor:innen

Composite hiatoplastyCrural reinforcementHernia recurrenceHiatus hernia repairPosterior hiatoplasty

Autor:innen und Institutionen

  • Division of General Surgery, Department of Biomedical Science for Health, I.R.C.C.S. Ospedale Galeazzi - Sant'Ambrogio, University of Milan, Via C. Belgioioso, 173, Milan, 20157, Italy.
  • Division of General Surgery, Department of Biomedical Science for Health, I.R.C.C.S. Ospedale Galeazzi - Sant'Ambrogio, University of Milan, Via C. Belgioioso, 173, Milan, 20157, Italy. davide.bona@unimi.it.
  • Department of Biomedical Sciences for Health, Division of General and Foregut Surgery, University of Milan, IRCCS Policlinico San Donato, Milan, Italy.
  • Division of General Surgery, Department of Surgery, I.R.C.C.S. Ospedale Galeazzi- Sant'Ambrogio, University of Insubria, Milan, Italy.

ORCID-Profile: Davide Bona

Zitieren

APA

Aiolfi, A., Bona, D., De Bernardi, S., Lombardo, F., Manara, M., Bonitta, G., Wang, Q., Cavalli, M., Campanelli, G., & Bonavina, L. (2025). Evaluation of the safety and effectiveness of crural reinforcement with bio-a® or phasix-st® mesh: results from a multicenter study. Hernia. https://doi.org/10.1007/s10029-025-03516-3

Vancouver

Aiolfi A, Bona D, De Bernardi S, Lombardo F, Manara M, Bonitta G, et al. Evaluation of the safety and effectiveness of crural reinforcement with bio-a® or phasix-st® mesh: results from a multicenter study. Hernia. 2025. doi:10.1007/s10029-025-03516-3

BibTeX
@article{Aiolfi2025,
  author = {Aiolfi, Alberto and Bona, Davide and De Bernardi, Sara and Lombardo, Francesca and Manara, Michele and Bonitta, Gianluca and Wang, Quan and Cavalli, Marta and Campanelli, Giampiero and Bonavina, Luigi},
  title = {Evaluation of the safety and effectiveness of crural reinforcement with bio-a® or phasix-st® mesh: results from a multicenter study},
  journal = {Hernia},
  year = {2025},
  doi = {10.1007/s10029-025-03516-3}
}
Kostenlos starten →